Imaging Features of Acute Encephalopathy in Patients with COVID-19: A Case Series

S Kihira1, B N Delman1, P Belani1

  • 1From the Departments of Diagnostic, Molecular and Interventional Radiology (S.K., B.N.D., P.B., A.A., B.R., J.S., A.H.D., P.S.P.).

Insights

This study highlights key brain imaging findings in five patients with coronavirus disease 2019 (COVID-19) and acute encephalopathy. Radiologists should recognize these diverse neuroradiologic features associated with COVID-19 neurological complications.

Area of Science:

  • Neurology
  • Radiology
  • Infectious Diseases

Background:

  • The World Health Organization declared coronavirus disease 2019 (COVID-19) a global pandemic on March 11, 2020.
  • Limited data exists on the brain imaging characteristics of COVID-19 patients.
  • Acute encephalopathy is a potential neurological complication of COVID-19.

Purpose of the Study:

  • To present five cases illustrating the varied neuroimaging findings in patients with COVID-19 and acute encephalopathy.
  • To increase awareness among radiologists regarding the spectrum of neuroradiologic manifestations of COVID-19-associated encephalopathy.

Main Methods:

  • Retrospective case series analysis.
  • Review of magnetic resonance (MR) imaging features in five patients diagnosed with COVID-19 and acute encephalopathy.
  • Detailed description of observed neuroradiologic findings.

Main Results:

  • Observed MR features included leukoencephalopathy, diffusion restriction in gray matter (GM) and white matter (WM), microhemorrhages, and leptomeningitis.
  • The cases demonstrated a range of acute encephalopathy presentations in the context of COVID-19.
  • Imaging findings varied across the presented cases.

Conclusions:

  • The neuroradiologic imaging spectrum of acute encephalopathy in COVID-19 patients is diverse.
  • Familiarity with these findings is crucial for radiologists managing patients with COVID-19.
  • Early recognition of these brain imaging features may aid in the diagnosis and management of neurological complications in COVID-19.